Most Recent
Lawyer plans complaint to legal watchdog against Banksia team over fees in second class action
The legal watchdog in Victoria will be asked to probe potential misconduct against the legal team behind the controversial Banksia Securities class action for their fees in a separate class action, which last year settled for $40 million.
Directed Electronics seeks $18M from Isuzu for alleged contract, copyright breaches
Australian auto electronics company Directed Electronics is seeking at least $18 million from truck company Isuzu for allegedly breaching a contract for the supply of a new audio visual unit and aiding a former employee's alleged theft of company information.
VW rightly hit with $125M fine after ‘starving’ judge of evidence, court told
An appeals court has been urged to uphold a judge's $125 million penalty against Volkswagen in the ACCC's case over the car maker's emissions cheating, with a court-appointed contradictor saying the judge was "starved" of the information he required to assess whether a $75 million agreement brokered by the consumer watchdog was reasonable.
Sandoz wins appeal of $26.3M infringement ruling in IP battle over Lexapro
Generic drug maker Sandoz has successfully appealed a $26.3 million judgment finding it infringed a patent owned by rival H Lundbeck relating to the top-selling antidepressant Lexapro.
Commonwealth Bank, Westpac’s BT face potential class actions over insurance ‘rort’
Shine Lawyers is investigating two new class actions against Commonwealth Bank of Australia and Westpac's BT Funds Management over allegedly excessive insurance premiums, a week after filing a similar case against AMP's life insurance arm.
ASIC scores ‘narrow’ win in case against ex-Tennis Australia director
A judge has handed ASIC a "narrow" win in its action against former Tennis Australia director Harold Mitchell, tossing most of the regulator's case and accusing it of "confirmatory bias".
Westpac’s anti-money laundering woes worsen
Westpac anti-money laundering compliance troubles continue to worsen, with the bank reporting an additional 365,000 incomplete or inaccurate threshold transaction reports to AUSTRAC.
Mylan loses Lipidil appeal, despite court finding proof of intention not needed for Swiss-style claims
Mylan Health has lost its challenge to a ruling that invalidated three patents related to its blockbuster cholesterol drug Lipidil, despite the appeals court finding the primary judge had erred by ruling that proof of intention was required for Swiss-style claims.
Sequenom’s ‘incorporeal’ prenatal genetic test unpatentable, Ariosa tells Full Court
Ariosa Diagnostics is fighting to revoke a patent for noninvasive prenatal test owned by Sequenom, arguing it merely describes how to extract "incorporeal" genetic information that is naturally found within the DNA of an unborn foetus.
ACCC takes Pacific National, Aurizon terminal deal challenge to High Court
The competition regulator wants the High Court to hear its challenge to Pacific National's $205 million acquisition of Aurizon's Acacia Ridge Terminal in Queensland, saying the deal would entrench the rail freight carrier's near monopoly on the east coast of Australia.